Irbesartan and Aggrastat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 5 people who take Irbesartan and Aggrastat. Common interactions include haematocrit decreased among females, and renal failure among males.

The phase IV clinical study analyzes what interactions people who take Irbesartan and Aggrastat have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

5 people who take Irbesartan and Aggrastat together, and have interactions are studied.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is used in high blood pressure. Currently, eHealthMe is studying from 33,691 Irbesartan users.

What is Aggrastat?

Aggrastat has active ingredients of tirofiban hydrochloride. Currently, eHealthMe is studying from 3,696 Aggrastat users.

Number of Irbesartan and Aggrastat reports submitted per year:

Common Irbesartan and Aggrastat drug interactions by gender *:

female:

Haematocrit decreased
Haemoglobin decreased
Pulmonary alveolar haemorrhage

male:

Renal failure
Thrombocytopenia
Coronary artery stenosis
Haematocrit decreased
Haemoglobin decreased
Haemorrhage
Post procedural haemorrhage

Common Irbesartan and Aggrastat drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Thrombocytopenia

60+:

Renal failure
Coronary artery stenosis
Haematocrit decreased
Haemoglobin decreased
Haemorrhage
Post procedural haemorrhage
Thrombocytopenia

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and Aggrastat?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Irbesartan side effects (33,691 reports)
Aggrastat side effects (3,696 reports)

Common Irbesartan drug interactions:

Irbesartan and Amlodipine: 5,648 reports
Irbesartan and Metformin: 5,345 reports
Irbesartan and Furosemide: 4,231 reports
Irbesartan and Aspirin: 3,785 reports
Irbesartan and Zide: 3,173 reports
Irbesartan and Hydrochlorothiazide: 3,170 reports
Irbesartan and Omeprazole: 3,160 reports
Irbesartan and Pantoprazole: 2,528 reports
Irbesartan and Allopurinol: 2,150 reports
Irbesartan and Simvastatin: 2,144 reports

Browse interactions between Irbesartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aggrastat drug interactions:

Aggrastat and Heparin: 1,750 reports
Aggrastat and Aspirin: 1,341 reports
Aggrastat and Clopidogrel: 948 reports
Aggrastat and Nitroglycerin: 239 reports
Aggrastat and Plavix: 228 reports
Aggrastat and Clopidogrel bisulfate: 201 reports
Aggrastat and Ticagrelor: 156 reports
Aggrastat and Metoprolol tartrate: 102 reports

Browse interactions between Aggrastat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan and tirofiban hydrochloride (the active ingredients of Irbesartan and Aggrastat, respectively), and Irbesartan and Aggrastat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Irbesartan and Aggrastat.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Mirtazapine and Ibuprofen And Diphenhydramine Citrate drug interaction - now
Metformin and Blood Calcium Increased - 4 seconds ago
Glipizide and Azmacort drug interaction - 31 seconds ago
Hydrocortisone and Dynacin drug interaction - 31 seconds ago
Leukine and Haematuria Aggravated - 40 seconds ago
Imodium and Ketorolac Tromethamine drug interaction - 50 seconds ago
Duragesic and Pelvic Pain - a minute ago
Cromolyn Sodium and Baraclude drug interaction - a minute ago
Methadone Hydrochloride and Lactobacillus Acidophilus drug interaction - a minute ago
Thiotepa and Reglan drug interaction - a minute ago